Jonah D. Garry, Evan L. Brittain. "Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data." Circulation, 2026. doi:10.1161/circulationaha.126.079012